Evidence map›Paper›PMID 22374506›Full record

ArticleToxicology2012

In utero exposure to benzo(a)pyrene predisposes offspring to cardiovascular dysfunction in later-life.

G E Jules, S Pratap, A Ramesh, D B Hood

Abstract read
In one paragraph

Article in Toxicology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Transcriptomic Changes in Zebrafish Embryos and Larvae Following Benzo[a]pyrene Exposure.Toxicological sciences : an official journal of the Society of Toxicology · 2015
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

G E JulesDepartment of Neuroscience and Pharmacology, Environmental-Health Disparities and Medicine, Center for Molecular and Behavioral Neuroscience, Meharry Medical College, Nashville, TN 37208, USA.
S Pratap
A Ramesh
D B Hood
Meharry Medical College · US

Funding

VITAMIN D DEFICIENCY AND INCREASED RISK OF UTERINE FIBROIDS IN AFRICAN AMERICANSG12RR003032 · NCRR · MEHARRY MEDICAL COLLEGE · PI LIU, BINDONG · 1985 to 2011
$27.4M
Technologies and Resources CoreU54MD007593 · NIMHD · MEHARRY MEDICAL COLLEGE · PI ADUNYAH, SAMUEL EVANS · 2012 to 2018
$24.7M
Training/Education CoreP20MD000516 · NIMHD · MEHARRY MEDICAL COLLEGE · PI ZOOROB, ROGER J · 2003 to 2013
$14.2M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54RR026140 · NCRR · MEHARRY MEDICAL COLLEGE · PI GOODWIN, JEFFREY SHAWN · 2009 to 2011
$12.9M
SNRP PROJECT AT MEHARRY MEDICAL COLLEGEU54NS041071 · NINDS · MEHARRY MEDICAL COLLEGE · PI CHARLTON, CLIVEL G. · 2000 to 2008
$9.2M
Meharry RCMI Program in Women's Health ResearchG12MD007586 · NIMHD · MEHARRY MEDICAL COLLEGE · PI HILDRETH, JAMES E · 2012 to 2016
$7.8M
RESEARCH PROJECT: "Mechanisms of B(a)P Induced Neurotoxicity"S11ES014156 · NIEHS · MEHARRY MEDICAL COLLEGE · PI HOOD, DARRYL BRICE · 2006 to 2010
$3.8M
Alliance for Research Training in NeuroscienceT32MH065782 · NIMH · VANDERBILT UNIVERSITY · PI BUSH, ELAINE SANDERS · 2002 to 2006
$2.6M
Mechanisms for Benzo(a)pyrene-Induced Colon Cancer Exacerbation by Dietary FatR01CA142845 · NCI · MEHARRY MEDICAL COLLEGE · PI RAMESH, ARAMANDLA · 2010 to 2013
$1.2M
Mechanisms of Inhaled B(a)P-Induced NeurotoxicityR56ES017448 · NIEHS · MEHARRY MEDICAL COLLEGE · PI HOOD, DARRYL BRICE · 2010 to 2010
$285k
NCI NIH HHS 1R01CA142845-01A1NCI NIH HHS R01 CA142845NCRR NIH HHS G12 RR003032NCRR NIH HHS U54 RR026140NIEHS NIH HHS 1R56ES017448-01A1NIEHS NIH HHS R56 ES017448NIEHS NIH HHS S11 ES014156NIEHS NIH HHS S11ES014156-05NIMHD NIH HHS 3P20 MD000516-07S1NIMHD NIH HHS G12 MD007586NIMHD NIH HHS P20 MD000516NIMHD NIH HHS U54 MD007593NIMH NIH HHS T32 MH065782NIMH NIH HHS T32MH065782NINDS NIH HHS U54NS041071-002PHS HHS G12RRO3032
6 · The paper itself

Abstract

In utero exposure of the fetus to benzo(a)pyrene [B(a)P], a polycyclic aromatic hydrocarbon, is thought to dysregulate cardiovascular development. To investigate the effects of in utero B(a)P exposure on cardiovascular development, timed-pregnant Long Evans Hooded (LEH) rats were exposed to diluent or B(a)P (150, 300, 600 and 1200 μg/kg/BW) by oral gavage on embryonic (E) days E14 (the metamorphosing embryo stage) through E17 (the 1st fetal stage). There were no significant effects of in utero exposure to B(a)P on the number of pups born per litter or in pre-weaning growth curves. Pre-weaning profiles for B(a)P metabolite generation from cardiovascular tissue were shown to be dose-dependent and elimination of these metabolites was shown to be time-dependent in exposed offspring. Systolic blood pressure on postnatal day P53 in the middle and high exposure groups of offspring were significantly elevated as compared to controls. Microarray and quantitative real-time PCR results were directly relevant to a biological process pathway in animal models for "regulation of blood pressure". Microarray and quantitative real-time PCR analysis revealed upregulation of mRNA expression for angiotensin (AngII), angiotensinogen (AGT) and endothelial nitric oxide synthase (eNOS) in exposed offspring. Biological network analysis and gene set enrichment analysis subsequently identified potential signaling mechanisms and molecular pathways that might explain the elevated systolic blood pressures observed in B(a)P-exposed offspring. Our findings suggest that in utero exposure to B(a)P predispose offspring to functional deficits in cardiovascular development that may contribute to cardiovascular dysfunction in later life.

Indexed as

AnimalsBenzo(a)pyreneBody WeightCardiovascular DiseasesDose-Response Relationship, DrugFemaleFetusMiceNitric Oxide Synthase Type IIIPregnancyPrenatal Exposure Delayed EffectsRatsRats, Long-EvansRNA, MessengerSystoleTranscriptomeBenzo(a)pyreneNitric Oxide Synthase Type IIIRNA, Messenger

Identifiers

PMID22374506
PMCPMC3575114
OpenAlexW2001429680

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.